Novavax (NVAX) and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Va
Go back to Novavax (NVAX) and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Va| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.22 -0.12 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.34 | 52 Week High | $9.23 | |||
| Open | $10.50 | 52 Week Low | $1.16 | |||
| Day High | $10.75 | P/E | N/A | |||
| Day Low | $10.05 | EPS | $-0.30 | |||
| Volume | 5,125,029 | |||||
